跳至主要内容
临床试验/NCT04202393
NCT04202393已完成不适用

RCT to Improve Post-Hospital Treatment Adherence for Comorbid Substance Use and Bipolar Disorders

Butler Hospital1 个研究点 分布在 1 个国家目标入组 178 人开始时间: 2020年10月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
178
试验地点
1
主要终点
Clinician-Administered Rating Scale for Mania (CARS-M)

研究概览

简要总结

This trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric hospitalization. Half of the participants will receive a specialized psychosocial intervention program, while the other half will receive an enhanced safety monitoring program, both provided in addition to their routine care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of a bipolar-spectrum disorder
  • Diagnosis of a substance use disorder
  • Taking at least one mood-stabilizing medication

排除标准

  • Unable to speak and read English
  • Younger than age 18

研究组 & 干预措施

Safety Assessment and Follow-up Evaluation (SAFE)

Active Comparator

Enhanced symptom monitoring and safety evaluation over 6 months post-hospitalization.

干预措施: Safety Assessment and Follow-up Evaluation (SAFE) (Behavioral)

Integrated Treatment Adherence Program (ITAP)

Experimental

A combination of in-person and phone sessions along with significant other involvement over 6 months post-hospitalization.

干预措施: Integrated Treatment Adherence Program (ITAP) (Behavioral)

结局指标

主要结局

Clinician-Administered Rating Scale for Mania (CARS-M)

时间窗: 6 months

The Clinician-Administered Rating Scale for Mania (CARS-M) assesses mania symptom severity. Total scores range from 0 to 50 and higher scores indicated higher symptom severity.

Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C)

时间窗: 6 months

The Quick Inventory of Depressive Symptomatology - Clinician Rating (QIDS-C) assesses depressive symptom severity. Total scores range from 0 to 27 and higher scores indicated higher symptom severity.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验